This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rasouli, N. Articles by Elbein, S. C. Search for Related Content PubMed PubMed Citation Articles by Rasouli, N. Articles by Elbein, S. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Improved Glycemic Control in Subjects with Atypical Diabetes Results from Restored Insulin Secretion, But Not Improved Insulin Sensitivity

University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205

Address all correspondence and requests for reprints to: Dr. Neda Rasouli, Central Arkansas Veteran Health, 4300 West 7th Street, 111J, Little Rock, Arkansas 72205. E-mail: rasoulineda{at}uams.edu.

African-American subjects often present with hyperglycemic crisis (diabetic ketoacidosis or severe hyperglycemia), yet subsequently are treated without insulin. The pathophysiology of this unique condition is unknown. We hypothesized that recovery from atypical diabetes with intensive insulin therapy resulted from a reversal of a defect in ß-cell function and improved insulin sensitivity. We studied eight newly diagnosed, antibody-negative African-American subjects (age, 34–56 yr) who presented with hyperglycemic crisis. Subjects were studied at baseline after overnight glycemic control and again after 3 wk and 3 months of intensive insulin therapy. Insulin sensitivity (S_I) was determined from an insulin-modified, frequently sampled iv glucose tolerance test, and insulin secretion was measured as the acute insulin response to glucose and to a glucagon stimulation test. Fructosamine and hemoglobin A_1c declined significantly with intensive insulin therapy, and insulin requirements decreased over time. Both acute insulin response to glucose and the C peptide response to glucagon stimulation test improved by 3 wk (P = 0.02 vs. baseline), and improvements were maintained at 3 months (P = 0.02 vs. baseline). In contrast, the S_I remained low throughout the study. We demonstrate that improved glycemic control correlates with a remarkable recovery of ß-cell function, but no change in S_I.

This article has been cited by other articles:

				S. A. Imran and E. Ur Atypical ketosis-prone diabetes Can Fam Physician, November 1, 2008; 54(11): 1553 - 1554. [Full Text] [PDF]

				A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado Syndromes of Ketosis-Prone Diabetes Mellitus Endocr. Rev., May 1, 2008; 29(3): 292 - 302. [Abstract] [Full Text] [PDF]

				G. E. Umpierrez, D. Smiley, and A. E. Kitabchi Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med, March 7, 2006; 144(5): 350 - 357. [Abstract] [Full Text] [PDF]